DMTs Tied to Lower MS Relapse During Reproductive Therapy
Among patients with multiple sclerosis receiving assisted reproductive therapy, risk for relapse is increased only in those not treated with disease modifying therapy, new research suggests.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among patients with multiple sclerosis receiving assisted reproductive therapy, risk for relapse is increased only in those not treated with disease modifying therapy, new research suggests.
Relapse rates dropped to zero after an intensive regimen of autologous hematopoietic stem cell transplant, but improvement is greater with lower baseline disability.
The potent, once-daily oral BTK inhibitor tolebrutinib showed encouraging safety and efficacy results in patients with multiple sclerosis through 72 weeks in a new long-term extension of a phase 2b trial.
Spinal atrophy observed on MRI correlates with progression to secondary progressive MS when other signs may not be evident, new research shows.
Paramagnetic rim lesions on MRI show a high specificity for a diagnosis of multiple sclerosis; and higher numbers of the lesions are associated with worse disability, new research suggests.